ImmunityBio’s Anticipated FDA Approval Sparks Investment Deal ImmunityBio, a pharmaceutical company, announced that it has secured up to $320 million in financing and ...

Nkarta, a biopharmaceutical company based in South San Francisco, has seen a surge in its stock price following news that the U.S. Food ...

Pfizer, a renowned New York drugmaker, has recently achieved expanded approval from the U.S. Food and Drug Administration (FDA) for its powerful combination ...

Delcath Systems experienced a significant surge in their stock value, with shares rising over 60% in premarket trading on Tuesday. The interventional oncology ...